1/20/2025InflamaX Secures Pre-A Investment for Immuno-Inflammatory Research  

1/17/2025Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...

1/17/2025Simnova and Orna Expand Partnership to Include BCMA-Targeted RNA Thera...

1/17/2025Bivision Secures ~CNY 100M in Series A+ Financing, Accelerates Targete...

1/16/2025Hengrui Pharma Poised for Global Expansion, Eyes More Deals

1/16/2025Menarini and Insilico Forge Strategic Partnership to Address Unmet Nee...

1/16/2025Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...

1/16/2025Conjustar Biotech Completes CNY 100M Series Pre-A+ Financing

1/16/2025NHSA Issues Notice on Advancing Real-Time Settlement Reform for BMI Fu...

1/16/2025CDE Issues the Technical Guidelines for Clinical Risk Management Plans...

1/15/2025U.S. Tightens Export Controls on Biotech Equipment Over AI and Securit...

1/15/2025Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...

1/15/2025Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy

1/15/2025Longen Therapeutics Secures Over CNY 100M in Pre-A Financing

1/15/2025Chengdu MedGenCell Secures Strategic Investment for Cell Therapy Innov...

1/14/2025NHSA Hosts Roundtable on Supporting Innovative Drug Development

1/14/2025ImmuneOnco Begins Trial of Instil's NSCLC Drug in China

1/14/2025Biophytis Enters Exclusive Negotiations with a Chinese Pharma Firm to ...

1/14/2025CR Pharma Partners with NAMI to Explore Palbociclib for Alzheimer's Tr...

1/14/2025Ikena and Inmagene Biopharma Agree to Merger Deal

1/13/2025NMPA Announces Package Insert Revision of Human Albumin Injection

1/13/2025China's Dealmaking Slows as India and Other APAC Markets Emerge as Key...

1/13/2025Gentize Biopharma Secures ~CNY 100M in Pre-A Financing to Advance Vacc...

1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection

1/13/2025Okejian Bio Secures CNY 100M+ in Series A Financing to Advance Innova...

1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)

1/13/2025Regor Releases Phase 2a Topline Results for GLP-1 RGT-075

1/13/2025Livzon Group Discontinues LZM009 PD-1 Program Amid Strategic Rethink ...

1/13/2025J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...

1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...

Page:13/47 Total number of articles:1389: [First][<<] [11] [12] [13] [14] [15] [>>] [End]